Skip to main content
Kully Woodruff, MD, Medicine/Pediatrics, New Bern, NC

KullyLynnWoodruffMD

Medicine/Pediatrics New Bern, NC

Physician

Dr. Woodruff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Woodruff's full profile

Already have an account?

  • Office

    3252 Wellons Blvd
    New Bern, NC 28562
    Phone+1 252-636-2664
    Fax+1 252-636-8305

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine/Pediatrics, 2013 - 2017
  • University of Mississippi School of Medicine
    University of Mississippi School of MedicineClass of 2013, MD, Summa Cum Laude Alpha Omega Alpha, Phi Kappa Phi, Gold Humanism Honor Society
  • University of Mississippi
    University of MississippiBA, Biochemistry, 2004 - 2008

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2017 - 2025
  • WA State Medical License
    WA State Medical License 2020 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Pediatrics Pediatrics
  • American Academy of PediatricsNeonatal Resuscitation Program
  • American Heart AssociationAdvance Cardiovascular Life Support (ACLS) Program
  • American Heart AssociationBasic Life Support for Healthcare Providers (CPR and AED)
  • American Heart AssociationPediatric Advanced Life Support (PALS)

Research History

  • Undergraduate Research Assisstant to Abbas Gholipour Shilabin, Mark T. Hamann Laboratory, Department of Pharmacognosy, National Center for Natural Products Research, University of MississippiResearch focused on kahalalide F (KF), the largest and most biologically active cyclic peptide of the naturally occurring kahalalide family of depsipeptides. Goal of research was to prepare analogues of KF to optimize activity against a slate of pathogens, as well as cancerous cells.2006 - 2008

Professional Memberships